GemmaCert: Scientific Study Reveals Major Deviation Between Labelled and Actual CBD Potency in Commercial Products
Puff Puff Post
FEBRUARY 24, 2020
These results raise safety and efficacy concerns. billion by 2025 growing at an impressive CAGR of 32.6%. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. TEL AVIV, Israel , Feb.
Let's personalize your content